To determine whether the mice develop early signs of tau pathology, we undertook a semi-quantitative western blot approach to identify a potential increase in tau phosphorylation at sites previously been shown to have increased levels of tau phosphorylation in AD patients (Buée et al., 2000). Here, MAPT is linked to Alzheimer disease.